Effect of Adalimumab on Ankylosing Spondylitis: A three Month Clinical Response in Indian Scenario+

Journal Title: Journal of Medical Science And clinical Research - Year 2017, Vol 5, Issue 9

Abstract

Introduction: This study aimed to evaluate the clinical response and safety in patients of Ankylosing spondylitis (AS) from a Rheumatology clinic in Madhya Pradesh, city Indore, after three months of Adalimumab therapy. All the patients who fulfilled modified New York criteria for AS were enrolled in the study. Material and Methods: A total of 82 patients completed the study. The study was done initiating Adalimumab therapy due to lack of efficacy for NSAIDs and/or DMARDs were recruited consecutively from 31st December 2016 till 31st July 2017 in a Rheumatology clinic. The patients were evaluated for disease activity using the BASDAI which assesses fatigue, spinal pain, joint pain, joint swelling, areas of localized tenderness, and morning stiffness, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR). Functional limitation was evaluated using Bath AS Functional Activity Index (BASFI), which assesses activities related to functional anatomy, and the patient's ability to cope with everyday life .Spinal movement was evaluated using Bath AS Metrology Index (BASMI), which measures cervical rotation, tragus to wall distance, lumbar side flexion, modified Schober's, and intermalleolar distance. Result: The rate of improvement of Bath AS Disease Activity Index (BASDAI) (p< 0.0001), and Bath AS Metrology Index (BASMI) (p=0.0009) and BASFI (Bath Ankylosing spondylitis functional Index) were achieved (p value<0.001) after three months. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were significantly decreased (p< 0.0001, p<0.0001 respectively).No adverse effects were seen including tuberculosis in any of the patient. Significant improvement in Erythrocyte Sedimentaion Rate (ESR), C-Reactive Protein (CRP) was also seen after 3 months (P-value <0.001, P-value<0.001) Patients who showed inadequate response to conventional therapy for AS showed significant improvement with Adalimumab treatment in disease activity as well as inflammatory markers. Conclusion: Patients who showed inadequate response to conventional therapy for AS showed significant improvement with Adalimumab treatment in disease activity as well as inflammatory markers.

Authors and Affiliations

Dr Akshat Pandey

Keywords

Related Articles

Comparative evaluation of the Modified Mallampati Score (MMC) and Modified Mallampati Score along with Thyromental distance, Anatomical abnormality, and Cervical mobility (M-TAC) in predicting difficult airway

Background: The MMC has been found to be of limited value and cannot be relied on for using in predicting difficult airway. Thus, we used a combination of multiple tests (combining MMC with Thyromental distance, Anatomic...

Fetal Cerebral Umbilical Doppler Ratio in Prediction of Adverse Perinatal Outcome in Patient with Preeclampsia

Objectives: This study was undertaken to evaluate the role of middle cerebral to umbilical artery blood velocity waveform's systolic/diastolic ratio (MCA/UA) and compare with biophysical profile as a predictor of adverse...

Study of Psychosocial Factors in Young and Elderly Asthmatics

Introduction: Asthma affects the children, young, as well as elderly populations. Psychosocial factors have been extensively studied in children and younger asthmatics. They can have a significant impact in the elderly a...

An Etiological Study of Acute Kidney Injury in Patients at Tertiary Care Hospital in Navi Mumbai

Aims and Objective: To determine the etiology of acute kidney injury Material and Method: In our study 100 patients admitted in MGM hospital in medical ward and MICU with diagnosed AKI were enrolled. A detailed history w...

Study of dual plating in bicondylar fracture, our experience in 25 cases at J.L.N hospital and Research Centre Bhilai (C.G)

Background: Bicondylar fractures of tibia are common fractures occurring in young age groups. Appropriate management is necessary for optimal function and to prevent complications. Aims and Objectives: To determine the u...

Download PDF file
  • EP ID EP528180
  • DOI -
  • Views 65
  • Downloads 0

How To Cite

Dr Akshat Pandey (2017). Effect of Adalimumab on Ankylosing Spondylitis: A three Month Clinical Response in Indian Scenario+. Journal of Medical Science And clinical Research, 5(9), 27891-27896. https://europub.co.uk/articles/-A-528180